Sartorius provides customers in the biopharmaceutical industry, at biotech start-ups and in science, the tools and technologies to achieve breakthroughs. We empower scientists and engineers to simplify progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine. Together, we’re setting new standards in cell & gene therapy with robust, scalable and regulatory compliant solutions to bring our customers' life-changing therapies to market.

Learn more at Cell and Gene Therapy | Sartorius

Title : Walking the Tightrope | Balancing Process Optimization & Cost Implications to Improve CGT Accessibility

Speakers : David Ede & Behnam Partopour

Date : Wednesday 8 October

Time : 1:30pm - 2:30pm

Localisation : Room Parallel D

In this interactive session, we will explore process optimization and economic modelling for both autologous CAR-T cell therapy and AAV-based gene therapy. Cost per run, cost per batch, cost per treatment, cost per dose – in the journey from cell and gene therapy discovery to delivery, cost considerations are everywhere, from starting and ancillary materials to labour and capital equipment. Optimizing the manufacturing process is critical to reducing cost per dose, but finding the right balance between process productivity and production costs remains a fundamental challenge for developers and manufacturers.

Join Sartorius for this informative and thought-provoking symposium and collect your voucher to receive a complimentary "Pops and Bubbles" snack box!* (while stocks last)